Profil
Christine Murray currently works at Cytokinetics, Inc., as Senior Vice President-Regulatory & Quality from 2023.
Ms. Murray also formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2019 to 2024, Achaogen, Inc., as Vice President-Regulatory Affairs from 2011 to 2015, Horizon Pharmaceutical LLC, as Vice President-Global Regulatory Affairs from 2015 to 2017, Raptor Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 2015 to 2017, and Ultragenyx Pharmaceutical, Inc., as Senior Vice President-Global Regulatory Affairs from 2018 to 2021.
Ms. Murray received her undergraduate degree from The University of Liverpool and graduate degree from Newcastle University.
Aktiva positioner av Christine Murray
| Företag | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Generell Rådgivare | 2023-04-01 |
Tidigare kända positioner av Christine Murray
| Företag | Position | Slut |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Direktör/Styrelseledamot | 2024-03-15 |
| ULTRAGENYX PHARMACEUTICAL INC. | Generell Rådgivare | 2021-09-01 |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Företagsledare/Principal | 2017-02-01 |
| RAPTOR PHARMACEUTICAL CORP | Generell Rådgivare | 2017-01-01 |
| ACHAOGEN | Generell Rådgivare | 2015-01-02 |
Christine Murrays utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University
Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















